Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Trinity Biotech provided a business update highlighting operational improvements, including the appointment of Jordi Romero as Head of Commercial Operations for Europe and the expansion of its PrePsia patent portfolio to nine granted U.S. and European patents. The company reported progress in its manufacturing transformation, having completed approximately 9 million TrinScreen HIV tests under an outsourced model and initiating production of Uni-Gold™ HIV tests.
Key figures
- Patents granted
- 9
- Trinscreen tests manufactured
- 9000000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.